e-learning
resources
Milan 2017
Monday, 11.09.2017
Molecular pathways in lung development
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mesenchymal Tsc2 deficiency causes retarded lung alveolarization and polycystic kidney lesion
S. Ren (Los Angeles, United States of America)
Source:
International Congress 2017 – Molecular pathways in lung development
Session:
Molecular pathways in lung development
Session type:
Poster Discussion
Number:
2084
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ren (Los Angeles, United States of America). Mesenchymal Tsc2 deficiency causes retarded lung alveolarization and polycystic kidney lesion. 2084
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Mesenchymal Tsc2 deficiency causes retarded lung alveolarization and polycystic kidney lesion
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021
Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Lipogenic switch of fibroblast to lipofibroblast induce lung regeneration in a model of bronchopulmonary dysplasia
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
Mesenchymal stem cells from adipose tissue reduce bleomycin-induced lung remodeling in late stage
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
The role of vascular endothelial growth factor D in diagnosis of polycystic lung diseases
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Mesenchymal stem cells and fibrotic lung diseases
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014
Dasatinib suppresses TGFbeta-induced epithelial mesenchymal transition and inhibits pulmonary fibrosis
Source: International Congress 2014 – ILDs 1
Year: 2014
Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017
Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Pro-fibrotic phenotype of human Hermansky-Pudlak syndrome lung fibroblasts
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept